Clinical trials
Observational Pancreatic Neoplasms trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 4 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 4 |
| Taipei Veterans General Hospital, Taiwan | 2 |
| Academia Sinica, Taiwan | 1 |
| Arbor Research Collaborative for Health | 1 |
| Chang Gung Memorial Hospital | 1 |
| Focused Ultrasound Foundation | 1 |
| National Cheng Kung University | 1 |
| National Cheng-Kung University Hospital | 1 |
| National Chung Hsing University | 1 |
| National Health Research Institutes, Taiwan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 15 |
| Pancreatic Cyst | 2 |
| Stomach Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Cholangiocarcinoma | 1 |
| Gastroparesis | 1 |
| Genetic Predisposition to Disease | 1 |
| Liver Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Neoplasm, Residual | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.